These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6369034)

  • 21. Cystine Stone Formers Have Impaired Health-Related Quality of Life Compared with Noncystine Stone Formers: A Case-Referent Study Piloting the Wisconsin Stone Quality of Life Questionnaire Among Patients with Cystine Stones.
    Streeper NM; Wertheim ML; Nakada SY; Penniston KL
    J Endourol; 2017 Apr; 31(S1):S48-S53. PubMed ID: 27717296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.
    Trinchieri A; Mandressi A; Luongo P; Longo G; Pisani E
    Br J Urol; 1991 Mar; 67(3):230-6. PubMed ID: 2021806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrence of upper urinary tract calculi].
    Mitsuhashi S; Hikage T; Kawamura K; Masukagami T; Matsuzaki A
    Hinyokika Kiyo; 1988 Sep; 34(9):1549-55. PubMed ID: 3213791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the true burden of kidney stone disease.
    Thongprayoon C; Krambeck AE; Rule AD
    Nat Rev Nephrol; 2020 Dec; 16(12):736-746. PubMed ID: 32753740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Characteristics and Risks Associated with Stone Recurrence in Korean Young Adult Stone Patients.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Kim WJ; Lee SC
    J Endourol; 2017 Aug; 31(8):806-811. PubMed ID: 28537440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.
    Schnierle P
    Experientia; 1995 Nov; 51(11):1068-72. PubMed ID: 7498447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
    Singh P; Enders FT; Vaughan LE; Bergstralh EJ; Knoedler JJ; Krambeck AE; Lieske JC; Rule AD
    Mayo Clin Proc; 2015 Oct; 90(10):1356-65. PubMed ID: 26349951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular calcification and bone mineral density in recurrent kidney stone formers.
    Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic investigation of stone formers].
    Bonny O; Bosshard P
    Ther Umsch; 2021 Jun; 78(5):235-240. PubMed ID: 34032135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stone recurrence predictive score (SRPS) for patients with calcium oxalate stones.
    Lee YH; Huang WC; Lu CM; Tsai JY; Huang JK
    J Urol; 2003 Aug; 170(2 Pt 1):404-7. PubMed ID: 12853786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal phosphate control as a reliable predictive factor of stone recurrence.
    Kim YJ; Kim TH; Yun SJ; Kim ME; Kim WJ; Lee SC
    J Urol; 2009 Jun; 181(6):2566-72; discussion 2572. PubMed ID: 19375105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
    Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
    Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of single stone-formers.
    Mallette LE
    Am J Med; 1982 Apr; 72(4):559-60. PubMed ID: 7072741
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary stone disease: a practical guide to metabolic evaluation.
    McDonald MW; Stoller ML
    Geriatrics; 1997 May; 52(5):38-40, 49-52, 55-6. PubMed ID: 9152217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic evaluation and medical therapy for stone formation.
    Krautschick AW
    Curr Opin Urol; 1999 Jul; 9(4):335-8. PubMed ID: 10459471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urolithiasis: Update on Metabolic Evaluation of Stone Formers.
    Park S; Pearle MS
    ScientificWorldJournal; 2005; 5():902-914. PubMed ID: 29861685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Economic aspects of evidence-based metaphylaxis].
    Strohmaier WL
    Urologe A; 2006 Nov; 45(11):1406-9. PubMed ID: 17063349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.